Pilot Study to Clinical Evaluate Lacrima Medical Device in Insomnia Patients
NCT02236845 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2016-08-16
Summary
The study will assess the safety, tolerability and feasibility of Lacrima investigational medical device vs. sham device in adult patients with chronic Insomnia
Conditions
- Chronic Insomnia
Interventions
- DEVICE
-
Lacrima Medical Device and sham comparator
Sponsors & Collaborators
-
Lacrima Medical LTD
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2016-07-31
- Completion
- 2016-08-31
Countries
- Israel
Study Locations
More Related Trials
-
A Study of LY2624803 in Japanese Participants With Transient Insomnia
NCT01784614 ·Status: COMPLETED ·Phase: PHASE1
-
An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia
NCT00784875 ·Status: COMPLETED ·Phase: PHASE2
-
Solriamfetol and CBT-I in Patients With Insomnia Disorder
NCT05838430 ·Status: COMPLETED ·Phase: PHASE4
-
A Polysomnographic Study to Compare the Efficacy of Gastric Retentive Zaleplon Accordion Pill to Placebo in Subjects With Insomnia
NCT01277107 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Experimental Sleep Disturbances on Receptor Function of Study Drug
NCT04299490 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Lactium on Sleep Disorders in Healthy Volunteers With Persistent Subclinical Insomnia
NCT06378034 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of LY2624803 in Participants With Transient Insomnia
NCT01779830 ·Status: COMPLETED ·Phase: PHASE1
-
An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia
NCT03338764 ·Status: WITHDRAWN ·Phase: PHASE3
-
Long-Term Efficacy of Ramelteon on Endocrine Function in Adult Subjects With Chronic Insomnia
NCT00656994 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Efficacy of Ramelteon in Adults With Chronic Insomnia
NCT00671125 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Lasmiditan on Simulated Driving Performance in Healthy Participants
NCT03459612 ·Status: COMPLETED ·Phase: PHASE1
-
Remote Ischemic Conditioning for the Treatment of Stroke-related Insomnia
NCT05289518 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder
NCT02841709 ·Status: COMPLETED ·Phase: PHASE2
-
Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)
NCT00094627 ·Status: COMPLETED ·Phase: PHASE3
-
The Use of Amber Glasses in Improving Sleep
NCT04751019 ·Status: COMPLETED ·Phase: NA
-
EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress
NCT07027657 ·Status: COMPLETED ·Phase: NA
-
Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)
NCT00094666 ·Status: TERMINATED ·Phase: PHASE3
-
Appraising Clinical Trial Experiences of Patients With Insomnia
NCT05978271 ·Status: NOT_YET_RECRUITING
-
A Study of LY3154207 on Sleep in Healthy Male Participants
NCT02603861 ·Status: COMPLETED ·Phase: PHASE1
-
6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia
NCT00352144 ·Status: COMPLETED ·Phase: PHASE3
-
Treatments for Insomnia in Patients With Parkinson's Disease
NCT01489982 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia
NCT00551148 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia.
NCT00671294 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and the Efficacy of a Sublingual Administration of Flumazenil to Reverse the Effect of Hypnotic Drugs in Healthy Adults
NCT01071889 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Effect of 2 Dosage Strengths of Lemborexant (E2006) on a Multiple Sleep Latency Test in Participants With Insomnia Disorder
NCT02350309 ·Status: COMPLETED ·Phase: PHASE1